torovirus
describ
enter
pathogen
caus
gastroenter
diarrhea
human
especi
children
well
young
domest
anim
high
import
livestock
industri
ie
calv
piglet
foal
envelop
posit
sens
singlestrand
rna
virus
belong
nidoviral
order
includ
four
famili
arterivirida
ronivirida
mesovirida
coronavirida
latter
contain
two
subfamili
coronavirina
genera
alpha
beta
delta
gammacoronaviru
torovirina
genera
bafiniviru
toroviru
intern
committe
taxonomi
virus
recogn
four
toroviru
speci
human
htov
bovin
btov
porcin
ptov
equin
toroviru
etov
prototyp
member
toroviru
genu
etov
strain
bern
viru
first
identifi
toroviru
bev
isol
diarrheic
hors
bev
first
adapt
cell
cultur
reason
best
character
toroviru
nevertheless
cellcultur
adapt
btov
strain
also
current
avail
toroviru
genom
consist
singl
rna
molecul
ca
kb
display
organ
similar
nidovirus
first
twothird
genom
carri
two
larg
overlap
open
read
frame
directli
translat
viral
genom
render
two
larg
polyprotein
proteolyt
process
virusencod
proteas
papainlik
proteinas
plp
main
proteinas
mpro
releas
replic
transcript
machineri
viru
compon
eg
rnadepend
rna
polymeras
rdrp
helicas
hel
amongst
other
rest
viral
genom
harbor
orf
encod
structur
protein
spike
membran
hemagglutininesteras
nucleocapsid
n
individu
express
nest
set
cotermin
subgenom
mrna
accumul
evid
differ
positivestrand
rna
virus
indic
heterogen
group
virus
genom
replic
transcript
invari
occur
close
associ
highli
modifi
cellular
membran
divers
origin
fact
presenc
doubl
membran
vesicl
dmv
cytoplasm
cell
infect
differ
nidovirus
associ
format
replic
transcript
complex
rtc
regard
recent
describ
presenc
dmv
cytoplasm
bevinfect
cell
provid
new
evid
support
notion
nidovirus
share
common
replic
structur
base
dmv
arrang
cluster
howev
mechan
host
factor
requir
gener
structur
remain
unknown
dmv
morpholog
akin
autophagosom
given
sever
pathogen
shown
hijack
autophagi
machineri
postul
positivestrand
rna
virus
may
exploit
autophagi
machineri
induc
dmv
format
autophagi
conserv
eukaryot
mechan
mediat
remov
longliv
cytoplasm
macromolecul
damag
organel
via
lysosom
degrad
pathway
maintain
cellular
homeostasi
autophagi
cytoplasm
materi
engulf
doublemembran
vesicl
term
autophagosom
later
fuse
lysosom
degrad
enclos
materi
lysosom
hydrolas
mani
autophagyrel
gene
atg
involv
format
regul
autophagi
pathway
class
iii
phosphatidylinositol
complex
contain
beclin
regul
initi
nucleat
autophagosom
membran
furthermor
two
ubiquitinlik
conjug
system
ie
involv
elong
closur
autophagosom
convert
cytosol
form
microtubul
associ
protein
light
chain
membran
associ
type
ii
mammalian
cell
contain
three
isoform
refer
b
c
wide
use
sever
studi
report
member
nidoviral
order
trigger
autophagi
host
cell
howev
specif
role
pathway
nidoviru
replic
remain
controversi
summar
cong
cowork
autophagi
may
play
opposit
effect
either
promot
viru
replic
exert
antivir
role
depend
viru
analysi
addit
unconvent
use
associ
mous
hepat
viru
mhv
equin
arter
viru
eav
member
coronavirida
arterivirida
famili
respect
although
canon
autophagi
requir
replic
two
virus
nonlipid
form
essenti
replic
howev
yet
noth
known
potenti
interplay
member
toroviru
genu
autophagi
studi
provid
evid
autophagi
induc
bevinfect
cell
monitor
autophagi
signal
protein
autophag
flux
furthermor
use
pharmacolog
agent
rna
interfer
modul
autophagi
pathway
analyz
effect
autophagi
machineri
bev
life
cycl
although
bev
infect
trigger
autophagi
respons
result
clearli
indic
cellular
pathway
irrelev
bev
replic
tissu
cultur
equin
dermal
e
derm
cell
atcc
human
fetal
lung
fibroblast
attc
hek
cell
atcc
cultur
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
nonessenti
amino
acid
gentamicin
penicillin
iuml
streptomycin
sigmaaldrich
fungizon
gibco
foetal
calf
serum
fc
e
derm
cell
rest
cell
equin
toroviru
strain
bern
bev
use
infect
e
derm
cell
monolay
describ
previous
multipl
infect
plaqueform
unit
per
cell
pfucel
use
experi
bev
inactiv
achiev
uvirradi
describ
previous
rabbit
polyclon
mous
monoclon
antibodi
purchas
sigmaaldrich
rabbit
polyclon
antibodi
beclin
well
mous
monoclon
antibodi
actin
purchas
santa
cruz
biotechnolog
addit
rabbit
polyclon
antibodi
purchas
cell
signal
rabbit
polyclon
antibodi
specif
n
rdrp
bev
protein
well
rat
polyclon
antibodi
specif
mpro
previous
describ
horseradish
peroxidaseconjug
alexa
fluorconjug
secondari
antibodi
purchas
sigmaaldrich
invitrogen
respect
mm
wortmannin
wn
balanc
salt
solut
ebss
ammonium
chlorid
mm
thapsigargin
nm
tg
dithiothreitol
mm
dtt
purchas
sigmaaldrich
hydroxychloroquin
hcq
purchas
sanofisynthelabo
epoxomicin
nm
epox
purchas
peptanova
plasmid
addgen
plasmid
gift
dr
tamotsu
yoshimori
plasmid
kindli
provid
dr
terj
johansen
lentivir
plasmid
express
mission
short
hairpin
rna
shrna
beclin
shrna
shrna
purchas
sigmaaldrich
lentivir
plasmid
express
scrambl
shrna
shrna
control
kindli
provid
dr
pablo
gastaminza
lentivir
packag
plasmid
pmdlgprre
addgen
plasmid
addgen
plasmid
prsvrev
addgen
plasmid
gift
dr
didier
trono
retrovir
psuperretropuro
vector
contain
shrna
sequenc
beclin
kindli
provid
dr
william
maltes
similar
retrovir
vector
contain
scrambl
shrna
sequenc
gener
describ
retrovir
packag
plasmid
pclampho
purchas
novu
biolog
cell
lyse
indic
time
pi
directli
laemmli
load
buffer
supplement
protein
lysat
subject
sdspage
transfer
nitrocellulos
membran
biorad
membran
block
h
trisbuff
salin
supplement
tween
tbst
contain
nonfat
dri
milk
later
incub
primari
antibodi
dilut
buffer
overnight
membran
wash
tbst
incub
appropri
dilut
correspond
horseradish
peroxidaselabel
secondari
antibodi
h
room
temperatur
wash
detect
immunoreact
protein
carri
use
enhanc
chemiluminesc
western
blot
detect
kit
ecl
ge
health
care
nonsatur
film
scan
rel
protein
valu
quantifi
gel
densitometri
use
imagej
softwar
accord
luke
miller
instruct
avail
http
altern
western
blot
imag
use
chemidoctmtouch
imagin
system
biorad
rel
protein
band
intens
determin
use
imag
lab
touch
softwar
provid
equip
e
derm
cell
infect
bev
harvest
indic
time
pi
wash
three
time
pb
process
rna
extract
rneasi
mini
kit
quiagen
follow
manufactur
instruct
revers
transcript
rt
reaction
perform
ng
rna
use
random
hexam
mixtur
roch
appli
scienc
primer
superscript
iii
revers
transcriptas
invitrogen
cdna
amplif
perform
abi
prism
sequenc
detect
system
appli
biosystem
use
power
sybr
green
master
mix
invitrogen
detect
viral
rna
oligonucleotid
primer
pair
design
base
bev
n
code
gene
nf
nr
housekeep
gene
hypoxanthin
phosphoribosyltransferas
use
normal
dilut
plasmid
contain
sequenc
amplifi
set
primer
run
parallel
use
establish
correspond
standard
curv
supernat
bevinfect
e
derm
cell
collect
product
infecti
extracellular
viru
determin
plaqu
assay
briefli
confluent
monolay
e
derm
cell
infect
tenfold
dilut
bevcontain
supernat
viru
adsorpt
cell
monolay
overlaid
mixtur
agar
contain
fc
mgml
deaedextran
h
pi
agar
overlay
remov
monolay
stain
crystal
violet
solut
methanol
determin
number
individu
virusinduc
lysi
plaqu
indic
time
pi
cell
grown
glass
coverslip
fix
paraformaldehyd
pfa
pb
process
immunofluoresc
use
standard
protocol
wash
pb
cell
permeabil
triton
pb
block
pb
contain
fc
immunofluoresc
analysi
antibodi
cell
fix
methanol
min
subsequ
block
pb
contain
fc
thereaft
cell
incub
primari
antibodi
dilut
pb
supplement
fc
humidifi
chamber
h
period
coverslip
wash
pb
incub
secondari
antibodi
conjug
either
alexa
fluor
dapi
nuclei
stain
coverslip
mount
microscop
slide
use
prolong
gold
antifad
reagent
invitrogen
imag
acquir
leica
tsc
confoc
laser
scan
microscop
step
size
e
derm
cell
transfect
plasmid
use
lipofectamin
invitrogen
h
posttransfect
sigmaaldrich
ad
cultur
medium
cell
clone
express
gfp
isol
clone
cylind
sigmaaldrich
use
trypsinedta
amplifi
convent
cultur
method
express
analyz
sever
clone
immunofluoresc
western
blot
use
antibodi
number
cytosol
dot
per
cell
determin
imagej
softwar
briefli
confoc
imag
acquir
leica
tsc
outlin
cell
interest
select
imagej
roi
manag
tool
dot
select
cell
count
use
analyz
particl
tool
use
automat
threshold
intermod
particl
size
two
pixel
percentag
cell
harbor
dot
calcul
consid
cell
dot
posit
one
determin
threshold
dot
per
cell
conclud
median
mockinfect
cell
sampl
invari
number
e
derm
cell
grown
coverslip
cellswel
transfect
plasmid
ngwell
use
lipofectamin
accord
instruct
h
posttransfect
cell
mocktreat
treat
indic
drug
infect
bev
indic
time
cell
process
immunofluoresc
analysi
describ
coloc
analys
perform
determin
pearson
correl
coeffici
use
jacop
tool
imag
j
softwar
retrovir
particl
produc
cell
mm
dish
cotransfect
retrovir
vector
psuperretropuro
express
shrna
sequenc
beclin
control
vector
express
scrambl
shrna
togeth
packag
plasmid
pclampho
use
lipofectamin
h
transfect
medium
replac
fresh
cultur
medium
h
later
supernat
contain
replicationdefect
retroviru
collect
filter
filter
use
transduc
e
derm
cell
gener
stabl
beclin
knockdown
cell
e
derm
cell
mm
dish
transduc
ml
supernat
contain
retroviru
togeth
polybren
sigmaaldrich
process
repeat
twice
h
posttransduct
pt
use
ml
supernat
polybren
h
pt
medium
replac
cell
maintain
fresh
cultur
medium
h
pt
puromycin
ad
cultur
medium
reach
concentr
day
select
period
cultur
maintain
regular
medium
supplement
puromycin
lentivir
particl
produc
cell
mm
dish
cotransfect
lentivir
vector
plasmid
express
shrna
beclin
plasmid
express
scrambl
shrna
control
togeth
packag
plasmid
pmdlgprre
prsvrev
use
standard
calcium
phosphat
transfect
protocol
h
later
transfect
medium
replac
fresh
cultur
medium
h
cell
supernat
contain
replicationdefect
lentivirus
collect
filter
filter
use
transduc
e
derm
cell
gener
stabl
cell
line
e
derm
cell
transduc
smallest
amount
supernat
suffici
confer
resist
puromycin
cell
describ
friesland
cowork
h
pt
puromycin
ad
cultur
medium
select
transduc
cell
day
cell
passag
maintain
regular
medium
supplement
puromycin
lentivir
particl
produc
cell
cotransfect
plasmid
packag
plasmid
describ
similarli
cell
select
puromycin
case
cell
maintain
day
pt
assay
perform
time
span
e
derm
cell
either
mockinfect
infect
bev
collect
differ
time
pi
subject
rna
extract
rt
reaction
describ
control
rna
also
extract
cell
treat
minut
mm
dithiotreitol
dtt
sigmaaldrich
nm
thapsigargin
tc
sigmaaldrich
result
cdna
amplifi
pcr
use
platinum
taq
dna
polymeras
invitrogen
specif
primer
amplif
ie
previous
describ
amplifi
dna
fragment
electrophores
agaros
gel
presenc
ethidium
bromid
invitrogen
positivestrand
rna
virus
capabl
subvert
autophagi
pathway
benefit
determin
possibl
effect
bev
infect
may
exert
autophagi
pathway
follow
guidelin
monitor
autophagi
first
examin
lipid
statu
endogen
protein
infect
cell
e
derm
cell
mockinfect
infect
bev
lyse
h
postinfect
pi
correspond
extract
use
western
blot
analysi
use
polyclon
antibodi
newli
synthes
bev
n
protein
also
analyz
monitor
viru
infect
addit
control
use
extract
e
derm
cell
treat
h
ammonium
chlorid
compound
impair
autophagosom
lysosom
fusion
therebi
autophagosom
degrad
wortmannin
wn
block
autophagi
target
shown
fig
mockinfect
cell
show
ii
level
similar
detect
lipid
defici
wntreat
cell
contrast
bev
infect
result
increas
ratio
h
pi
rel
uninfect
cell
similarli
ratio
alter
cell
autophagosomelysosom
fusion
impair
densitometr
analysi
correspond
protein
band
confirm
gradual
increas
ratio
along
infect
fig
also
sought
determin
whether
observ
enhanc
ratio
depend
upon
viral
replic
rather
direct
consequ
viru
entri
e
derm
cell
mockinfect
infect
bev
incub
equival
amount
uvinactiv
bev
bevi
collect
h
pi
analyz
western
blot
expect
bev
n
polypeptid
detect
bevitr
cell
indic
absenc
viral
replic
fig
regard
protein
cell
incub
bevi
show
lipid
akin
observ
mockinfect
cell
protein
correspond
form
howev
mention
cell
infect
bev
show
signific
increas
rel
ii
abund
compar
found
mockinfect
cell
bevitr
cell
inde
result
show
bev
replicationcompet
viru
requir
caus
accumul
ii
anoth
use
criterion
studi
autophagi
pathway
redistribut
intracellular
diffus
local
characterist
punctat
cytoplasm
pattern
ii
autophagi
vesicl
analyz
whether
bev
infect
affect
autophagi
pathway
gener
e
derm
cell
express
heterolog
report
protein
assess
correct
redistribut
autophagi
cell
treat
h
autophagi
inhibitor
prevent
autophagosom
format
inhibit
class
iii
hydroxichoroquin
hcq
specif
block
lysosomemedi
proteolysi
ebss
starvat
medium
induc
autophagi
pathway
control
cell
maintain
regular
cultur
medium
shown
fig
cell
lipid
impair
treatment
polypeptid
show
diffus
cytoplasm
local
howev
autophagi
induct
starvat
autophagi
flux
blockad
hcq
treatment
protein
report
distribut
form
punctat
structur
control
cell
protein
mostli
show
diffus
cytoplasm
local
cell
howev
sinc
autophag
flux
impair
punctat
structur
could
also
observ
cell
redistribut
differ
condit
confirm
cell
mockinfect
infect
bev
fix
h
pi
immunolabel
antimpro
antibodi
monitor
viru
infect
expect
mockinfect
cell
report
exhibit
domin
diffus
pattern
infect
cell
show
clear
punctat
distribut
fig
akin
observ
starv
well
hcqtreat
cell
fig
similar
assay
subsequ
perform
determin
percentag
cell
popul
harbor
dot
control
dot
detect
untreat
well
hcq
ebsstreat
cell
quantifi
cell
fix
three
time
point
ie
h
pi
cell
exhibit
dot
consid
posit
fig
quantit
studi
show
statist
signific
increas
percentag
infect
cell
bear
dot
h
pi
compar
found
mockinfect
cultur
howev
signific
differ
detect
h
pi
similarli
ebss
hcqtreat
cultur
show
signific
increas
percentag
posit
cell
compar
found
untreat
control
monolay
although
total
dot
number
per
cell
highli
variabl
valu
significantli
higher
cell
infect
bev
h
well
cell
treat
ebss
hcq
fig
overal
result
suggest
number
autophagosom
increas
bevinfect
cell
h
pi
respect
mockinfect
cell
although
increas
could
due
activ
autophagi
pathway
bev
point
rule
possibl
autophagosom
degrad
could
block
bev
infect
would
promot
accumul
recent
observ
dengu
viru
infect
cell
mention
increas
amount
autophagosom
due
either
induct
autophagi
inhibit
flux
autophagosom
degrad
check
whether
bev
infect
induc
autophagosom
accumul
via
inhibit
autophag
flux
autophagosom
acidif
monitor
use
vector
express
fusion
protein
use
construct
base
fact
gfp
signal
quench
acid
environ
wherea
mcherri
signal
remain
stabl
condit
allow
monitor
autophagosom
format
well
subsequ
autophagosomelysosom
autolysosom
fusion
step
order
valid
assay
e
derm
cell
transfect
vector
h
posttransfect
cultur
treat
h
autophagi
inhibitor
hcq
maintain
either
starvat
ebss
regular
medium
fig
treatment
protein
show
expect
pattern
ie
diffus
local
normal
condit
control
characterist
punctat
distribut
autophagi
vesicl
autophagi
activ
vesicl
nonacid
vesicl
autophagosom
thu
display
mcherrri
red
gfp
green
fluoresc
acid
vesicl
autolysosom
show
red
fluoresc
starvat
condit
flux
activ
type
vesicl
detect
howev
autophag
flux
block
agent
impair
lysosom
acidif
hcq
treatment
neutral
structur
simultan
exhibit
red
green
fluoresc
found
analyz
whether
autophag
flux
inhibit
bev
infect
e
derm
cell
transfect
vector
h
posttransfect
cultur
mockinfect
infect
bev
h
pi
cell
fix
process
immunofluoresc
analysi
use
specif
antibodi
bev
mpro
proteas
observ
fig
cell
infect
bev
display
activ
flux
akin
found
cell
subject
starvat
ebss
harbor
acid
neutral
vesicl
confirm
observ
mcherrygfp
coloc
assess
determin
correl
coeffici
r
fig
expect
high
correl
valu
obtain
autophag
flux
block
hcq
r
averag
respect
howev
autophagi
flux
activ
starvat
condit
ebss
lower
correl
mcherrygfp
detect
r
averag
significantli
similar
situat
observ
bevinfect
cell
show
r
averag
despit
r
valu
cell
cell
fluctuat
statist
signific
differ
ebsstreat
bevinfect
cell
contrast
hcqtreat
cell
show
signific
differ
compar
bevinfect
ebsstreat
cell
assess
also
call
sequestosom
cargo
receptor
protein
turnov
also
use
determin
autophagi
flux
degrad
indic
activ
flux
confirm
autophag
flux
remain
activ
bevinfect
cell
analyz
fate
protein
cours
infect
fig
unfortun
none
test
antibodi
recogn
equin
protein
e
derm
cell
therefor
experi
perform
use
human
cell
previous
describ
suscept
bev
infect
cell
mockinfect
infect
bev
collect
h
pi
addit
mockinfect
cell
treat
h
mm
hcq
proteasom
inhibitor
epoxomicin
nm
use
control
first
determin
whether
autophagi
pathway
also
alter
bevinfect
cell
cell
extract
analyz
western
blot
antibodi
shown
fig
convers
ii
detect
h
pi
viru
infect
monitor
western
blot
use
antibodi
bev
n
polypeptid
expect
gradual
increas
rel
n
protein
accumul
observ
cours
infect
significantli
clear
reduct
rel
intens
compar
mockinfect
cell
observ
h
pi
respect
contrast
increas
accumul
observ
drugtreat
cell
result
clearli
demonstr
bev
infect
also
induc
autophagi
human
cell
line
block
autophagi
flux
order
evalu
impact
autophagi
pathway
bev
replic
first
analyz
effect
pharmacolog
modul
pathway
might
exert
bev
infect
e
derm
cell
pretreat
h
ebss
wn
thereaft
cultur
infect
bev
maintain
regular
medium
without
inhibitor
h
control
cultur
maintain
regular
cultur
medium
throughout
whole
experi
infect
cell
extract
analyz
western
blot
check
effect
differ
treatment
autophagi
modul
fig
expect
lipid
impair
follow
treatment
wn
consequ
ii
level
neglig
control
cell
howev
cell
autophagosom
degrad
prevent
protein
larg
found
ii
ebssstarv
cell
autophag
flux
remain
activ
thu
allow
simultan
autophagosom
format
degrad
accordingli
rel
low
ii
proport
observ
condit
cell
infect
bev
correspond
supernat
collect
h
pi
extract
use
quantifi
extracellular
viru
product
observ
fig
signific
variat
extracellular
bev
yield
detect
follow
describ
pharmacolog
treatment
assess
valid
result
similar
experi
perform
treat
cultur
proteasom
inhibitor
previous
establish
inhibit
bev
replic
expect
reduct
exceed
one
unit
extracellular
viru
titer
attain
data
shown
view
result
gather
pharmacolog
agent
extend
studi
use
specif
short
hairpin
rna
shrna
target
two
key
player
autophagi
pathway
first
beclin
defici
cell
gener
transduc
e
derm
cell
lentivir
vector
express
shrna
beclin
mrna
similarli
shrna
control
cell
gener
transduc
e
derm
cell
lentivir
vector
express
scrambl
shrna
sequenc
cell
transduc
beclin
control
shrna
well
untransduc
e
derm
cell
wt
mock
infect
infect
bev
lyse
h
pi
analyz
western
blot
use
antibodi
beclin
antibodi
specif
recogn
bev
n
protein
also
use
monitor
viru
infect
observ
fig
amount
beclin
strongli
diminish
beclin
defici
cell
exhibit
reduct
compar
control
cell
remain
unalt
bev
infect
expect
ii
convers
decreas
beclin
defici
cell
show
ii
level
infect
cell
similar
detect
mockinfect
wt
control
cell
yet
slightli
higher
found
mockinfect
beclin
defici
cell
remain
express
beclin
lentiviru
transduc
cell
could
account
presenc
minor
ii
band
observ
infect
cell
significantli
condit
express
n
viral
protein
similar
detect
wt
control
bevinfect
cell
assess
effect
beclin
silenc
bev
infect
extracellular
viral
yield
determin
use
infect
cell
supernat
collect
h
pi
shown
fig
signific
chang
product
infecti
bev
detect
compar
autophagi
defici
cell
lack
beclin
control
cell
similar
result
obtain
use
e
derm
cell
transduc
anoth
retrovir
vector
express
differ
shrna
beclin
fig
data
gather
pharmacolog
agent
well
silenc
key
autophagi
protein
beclin
suggest
classic
autophagi
requir
bev
infect
nevertheless
autophagyindepend
function
viru
replic
describ
nidovirus
determin
whether
protein
might
also
exert
autophagi
independ
role
bev
life
cycl
defici
cell
gener
e
derm
cell
transduc
lentivir
vector
express
shrna
shrna
shrna
scrambl
shrna
sequenc
cell
transduc
control
shrna
mockinfect
infect
bev
lyse
h
pi
analyz
western
blot
antibodi
specif
bev
n
polypeptid
control
cell
autophagosom
degrad
impair
treatment
h
also
includ
experi
rel
amount
significantli
diminish
defici
cell
line
reduct
total
amount
protein
compar
control
cell
fig
like
previou
assay
beclin
amount
viral
protein
accumul
bev
infect
similar
obtain
infect
control
cell
addit
supernat
infect
cell
collect
h
pi
determin
viru
yield
signific
chang
defici
cell
control
cell
detect
fig
overal
result
show
although
bev
induc
autophagi
pathway
either
posit
neg
modul
pathway
significantli
affect
infect
outcom
determin
whether
autophag
flux
play
benefici
role
bev
replic
design
assay
autophagosom
degrad
inhibit
initi
establish
bev
replic
process
e
derm
cell
either
mockinfect
infect
bev
treat
hcq
h
pi
cultur
subsequ
maintain
regular
cultur
medium
end
assay
h
pi
cell
extract
analyz
western
blot
use
antibodi
fig
control
assess
correct
inhibit
autophagosom
degrad
hcq
set
mockinfect
cell
collect
conclud
correspond
treatment
h
pi
cell
accumul
ii
clearli
detect
fig
mock
nonetheless
autophagosom
degrad
restor
mockinfect
cell
harvest
end
experi
mock
h
observ
high
reduct
level
ii
respect
treat
cell
collect
h
pi
howev
infect
cell
major
chang
level
ii
treat
untreat
cell
observ
significantli
also
differ
accumul
n
viral
protein
addit
analyz
rtqpcr
amount
viral
rna
condit
found
signific
differ
level
viral
rna
accumul
treat
untreat
cell
fig
similar
result
obtain
infect
cell
supernat
collect
h
pi
use
quantifi
extracellular
viru
product
fig
result
clearli
indic
autophag
flux
play
role
bev
replic
howev
could
rule
possibl
effect
late
time
pi
bev
infect
induc
activ
autophag
flux
cell
case
polioviru
autophagi
play
benefici
role
infect
relat
matur
polioviru
particl
acid
vesicl
mind
treat
mock
bevinfect
e
derm
cell
hcq
h
pi
thu
block
autophagosom
degrad
period
maxim
extracellular
bev
product
shown
fig
autophagosom
degrad
inhibit
treat
cell
show
high
accumul
ii
protein
compar
untreat
mockinfect
cell
cell
infect
treat
condit
autophagi
flux
impair
signific
chang
accumul
neither
viral
n
protein
fig
viral
rna
fig
detect
similarli
autophag
flux
blockad
affect
product
infecti
extracellular
viral
particl
fig
ident
experi
also
carri
cell
case
extract
analyz
western
blot
use
antibodi
viral
n
protein
correspond
cell
supernat
use
viru
titrat
block
autophag
flux
late
infect
significantli
affect
bev
n
protein
accumul
fig
extracellular
viru
product
fig
experi
also
analyz
rel
amount
fig
amount
untreat
bevinfect
cell
significantli
reduc
compar
mockinfect
cell
reduct
similar
result
gather
compar
infect
cell
treat
autophagosom
degrad
inhibitor
vs
mockinfect
cell
treat
inhibitor
reduct
cell
treat
cell
treat
hcq
fig
taken
togeth
result
show
autophagi
pathway
activ
bev
infect
cell
late
replic
process
activ
irrelev
bev
life
cycl
tradit
autophagi
pathway
describ
nonselect
bulk
degrad
process
howev
last
year
process
describ
highli
select
protein
among
other
act
cargo
receptor
autophag
degrad
misfold
protein
aggreg
harbor
domain
known
mediat
selfoligomer
henc
respons
induc
format
aggreg
ii
ubiquitinbind
associ
uba
domain
iii
region
lir
provid
select
charg
ubiquitin
substrat
autophagosom
check
whether
bev
induc
select
autophagi
bevinfect
cell
process
immunofluoresc
use
antibodi
sinc
mention
none
test
antibodi
recogn
equin
protein
assay
perform
use
human
cell
order
visual
autophagosom
format
mock
bevinfect
cell
fix
h
pi
process
immunofluoresc
use
monoclon
antibodi
human
antimpro
antibodi
monitor
viru
infect
shown
fig
dot
accumul
h
pi
high
proport
locat
surround
mpro
signal
also
observ
infect
e
derm
cell
fig
next
use
antibodi
shown
fig
protein
exhibit
diffus
cytoplasm
local
mockinfect
cell
cell
infect
h
contrast
h
pi
aggreg
within
region
bev
mpro
local
coloc
mpro
protein
h
pi
evid
cell
exhibit
compact
mpro
aggreg
indic
advanc
state
infect
result
suggest
bev
might
induc
select
autophagi
order
remov
excess
bev
protein
accumul
late
time
pi
well
known
stress
condit
eukaryot
cell
maintain
er
homeostasi
promot
degrad
misfold
toxic
protein
use
ubiquitin
proteasom
system
erassoci
protein
degrad
erad
pathway
addit
accumul
evid
indic
autophagi
activ
surviv
mechan
cell
subject
er
stress
determin
whether
bev
induc
er
stress
test
induct
splice
xbox
bind
protein
transcript
factor
activ
er
stress
critic
involv
unfold
protein
respons
upr
mrna
splice
inositolrequir
enzym
respons
er
stress
thu
render
activ
transcript
factor
rna
sampl
mock
bevinfect
e
derm
cell
collect
h
pi
analyz
rtpcr
specif
primer
addit
rna
cell
treat
min
er
stressinduc
chemic
thapsigargin
tg
nm
dithiothreitol
dtt
mm
includ
assay
control
shown
fig
mockinfect
cell
mainli
contain
unsplic
mrna
form
although
small
amount
splice
one
also
detect
howev
bev
infect
caus
signific
increas
akin
observ
cell
treat
dtt
tg
rel
amount
splice
form
h
pi
clearli
result
suggest
bev
induc
er
stress
late
time
pi
although
comprehens
analysi
necessari
believ
excess
viral
protein
accumul
bev
late
pi
time
may
instrument
provok
er
stress
therebi
effort
mitig
cell
trigger
select
autophagi
respons
overal
examin
result
lead
us
rule
provir
role
autophagi
bev
infect
cell
sinc
differ
approach
use
modul
autophagi
produc
benefici
chang
bev
life
cycl
contrari
postul
autophagi
might
act
antivir
defens
mechan
trigger
host
cell
combat
bev
infect
howev
mechan
activ
late
time
pi
bulk
viru
progeni
alreadi
releas
thu
littl
effect
infect
outcom
describ
cumul
inform
indic
autophagi
highli
select
process
well
document
among
protein
act
cargo
receptor
autophag
degrad
aggreg
protein
damag
organel
well
remov
intracellular
parasit
presenc
protein
aggreg
surround
protein
close
proxim
bev
mpro
routin
found
howev
direct
coloc
mpro
clearli
detect
moreov
aggreg
appar
cell
advanc
stage
infect
mention
domain
involv
selfoligomer
aggreg
format
hypothes
form
larg
aggreg
mpro
molecul
expos
surfac
aggreg
could
interact
thought
lir
domain
although
depth
studi
yet
requir
observ
might
indic
bev
replic
trigger
select
autophagi
process
late
time
pi
viral
protein
substrat
degrad
line
view
also
observ
bev
induc
er
stress
time
autophagi
happen
therefor
accumul
viral
protein
late
time
pi
may
trigger
er
stress
consequ
cell
activ
select
autophagi
allevi
well
known
cell
respond
er
stress
activ
erad
pathway
stress
condit
lead
ubiquitin
misfold
protein
degrad
proteasom
howev
excess
accumul
misfold
protein
satur
proteasom
circumst
cell
respond
remov
ubiquitin
substrat
via
select
autophagi
nevertheless
futur
studi
would
necessari
precis
determin
role
protein
bev
replic
process
previou
studi
group
observ
bev
also
induc
apoptosi
activ
pkr
phosphoryl
translat
initi
factor
end
replic
process
viral
progeni
produc
seem
clear
autophagi
apoptosi
antivir
defens
mechan
overal
data
suggest
massiv
accumul
viral
protein
last
stage
bev
replic
process
may
primari
caus
er
stress
therebi
effort
mitig
stress
cell
respond
activ
autophagi
pathway
howev
shown
occur
coronavirus
incapac
amelior
stress
might
lead
cell
death
apoptosi
